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Abstract Lysosomes are thought to play a role in various
aspects of heavy metal metabolism. In the present study we
demonstrate for the first time the presence of a heavy metal ion
transport protein in the lysosomal membrane. Uptake of
radioactive silver both in highly purified lysosomal membrane
vesicles and in purified intact lysosomes showed the typical
kinetics of a carrier-mediated process. This transport was
stimulated by ATP hydrolysis, and showed specificity for Ag+,
Cu2+, and Cd2+. All biochemical properties of this lysosomal
metal ion transporter could classify it as a heavy metal
transporting P-type ATPase. Long Evans Cinnamon (LEC)
rats, an animal model for the copper transport disorder Wilson
disease, showed normal lysosomal silver transport.
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1. Introduction
Lysosomes are intracellular acid organelles which are
mainly responsible for the degradation of a variety of biolog-
ical macromolecules, derived from both extra- and intracellu-
lar constituents. Various speci¢c transport systems have been
characterized in the lysosomal membrane either for the release
of small degradation products or for the uptake of small sub-
strates [1]. Previously, we have developed a method for study-
ing transport across the lysosomal membrane using highly
puri¢ed lysosomal membrane vesicles. With this method, we
have characterized a sialic acid transporter, a glucose trans-
porter, and a chloride channel in the lysosomal membrane [2^
4]. For many years, lysosomes are also thought to play a role
in various aspects of the metabolism of heavy metals. For
instance, during hepatic copper overload the major route of
copper excretion is via exocytosis of lysosomal contents into
biliary canaliculi [5]. However, so far, direct evidence that
lysosomes are able to take up or exclude, sequester and mo-
bilize heavy metal ions by speci¢c transporters has been lack-
ing. The importance of mechanisms regulating copper metab-
olism is shown by the occurrence of severe diseases like
Menkes and Wilson disease. Both diseases are caused by ge-
netic defects in distinct steps of copper metabolism [6]. Trans-
port studies using radioactive copper are limited by its avail-
ability and short physical half-life (12.8 h). Recently, we have
shown that radioactive silver can replace copper in copper
transport studies [7]. This provides an excellent opportunity
to study copper transport mechanisms. In this paper we dem-
onstrate the presence of a heavy metal ion transport protein in
the lysosomal membrane. This transport protein is the ¢rst
heavy metal ion transporter detected in the lysosomal mem-
brane.
2. Materials and methods
2.1. Materials
110mAg was purchased from Amersham (speci¢c activity of 1 WCi/Wg
Ag). Seven-week-old Long Evans Cinnamon (LEC) rats were pur-
chased from Charles River Japan. All chemicals used were obtained
from Sigma or as indicated.
2.2. Preparation of lysosomal membranes vesicles and intact lysosomes
from rat liver
Highly puri¢ed lysosomal membrane vesicles were isolated from
livers of adult Wistar rats or 7-week-old LEC rats, as described earlier
[2]. Characteristics of LEC rats are described elsewhere [8]. The lyso-
somal membrane vesicles were suspended at a protein concentration
of 8^10 mg/ml in 50 mM KHEPES, pH 7.4, and were stored at
370‡C. Intact lysosomes were isolated from a liver of an adult Wistar
rat by Percoll gradient centrifugation [9]. The lysosomal/mitochon-
drial pellet of the above described procedure for lysosomal membrane
vesicles was resuspended in 5 ml 0.25 M sucrose/50 mM KHEPES,
pH 7.4, and was slowly loaded onto a Percoll gradient. The gradient
was made of 40% Percoll (Pharmacia) in 0.25 M sucrose/50 mM
KHEPES, pH 7.4. After 1 h centrifugation in a Beckmann Ti 45 rotor
(¢xed) at 20 000Ug at 4‡C, the gradient was divided in fractions of
1 ml. In all fractions the activity of the lysosomal enzyme L-hexosa-
minidase was determined, as described [10]. Fractions enriched in L-
hexosaminidase (60^80-fold over total homogenate) were combined
( þ 10 ml), diluted 6.5 times with 0.25 M sucrose/50 mM KHEPES,
pH 7.4, to dilute the Percoll concentration and centrifuged for 20 min
at 8000Ug in Ti 45 rotor at 4‡C. The pellet was used for transport
assays, performed immediately after preparation. Latency of the lyso-
somes was based on measurements of the activity of the intralysoso-
mal enzyme L-hexosaminidase in the presence and absence of the
detergent Triton X-100. The lysosomal latency of L-hexosaminidase
was approximately 72%.
2.3. Transport assays
Transport of 110mAg was measured into lysosomal membrane
vesicles or intact lysosomes. For the transport assays using lysosomal
membrane vesicles, the frozen membrane vesicles (70^120 Wg of pro-
tein in 10 Wl) were quickly thawed and pre-incubated with 50 mM
KHEPES, pH 7.4/10 mM reduced glutathione/5 WM valinomycin
(Boehringer Mannheim)/5 WM carbonyl cyanide p-tri£uoromethoxy-
phenylhydrazone (FCCP) for 10 min at room temperature (total vol-
ume 25 Wl). Glutathione (GSH) was added to reduce aspeci¢c binding
of Ag to the membrane. The ionophores valinomycin and FCCP were
added to prevent, respectively, the formation of a membrane potential
and the formation of a proton gradient due to stimulation of the
lysosomal H-ATPase by ATP. Simultaneously, radiolabeled 110mAg
(0.032 WCi) was pre-incubated with 10 mM reduced glutathione for
10 min at room temperature to allow the formation of an Ag-GSH
complex (1:1, total volume 10 Wl). After 10 min pre-incubation, the
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suspensions were pre-warmed at 37‡C for 3 min. The uptake experi-
ments at 37‡C were started by adding a 5-Wl aliquot of 32 mM
MgATP in 50 mM KHEPES, pH 7.4, to a 10-Wl aliquot of the
110mAg/GSH suspension and subsequently to a 25-Wl aliquot of the
pre-incubated membrane suspension. In control experiments ATP was
replaced by AMP (Boehringer Mannheim). Transport was terminated
by the addition of 60 Wl of ice-cold stop-solution (50 mM KHEPES,
pH 7.4) and 100 Wl were immediately applied to a Sephadex G50 ¢ne
(Pharmacia LKB) column (Pasteur pipettes, 0.5U5 cm), equilibrated
in cold stop-solution at 4‡C. Vesicles were eluted with 1 ml ice-cold
stop-solution. Vesicle-associated radioactivity was determined by
liquid scintillation counting in 10 ml Instagel (Packard). Aspeci¢c
binding of 110mAg to the membrane was determined either by 0 min
incubations at 0‡C (Fig. 1A) or by incubations at 37‡C in the presence
of high concentrations CuSO4 (s 100 WM, as indicated in the
legends), and subtracted from all determinations. Transport assays
using intact lysosomes were largely performed as described above
for the lysosomal membrane vesicles. However, 20-Wl aliquots of in-
tact lysosomes were used and all bu¡ers contained 0.25 M sucrose.
Inhibitors, like CuSO4, AgNO3, or other metal sulfates were applied
to the ATP solution and were added just before the start of the assay.
In the competitive inhibition experiments the 25 WM unlabeled CuSO4
and CdSO4 were added to the 110mAg/GSH suspension. The ATPase
inhibitors and protein modi¢er 4,4P-diisothiocyanostilbene-2,2P-disul-
fonic acid (DIDS) were added to the pre-incubation solution of the
lysosomal membrane vesicles. All experiments were performed in du-
plicate.
3. Results
3.1. Carrier mediated uptake of 110mAg in lysosomal membrane
vesicles
Studies on copper (Cu) transport have been greatly compli-
cated by the 64Cu isotope, which is not readily available and
has a very short physical half-life (12.8 h). Recently, we have
shown that copper transport can be easily measured using
radioactive silver (Ag) [7]. 110mAg is commercially available
and has a physical half-life of 250 days. We used this isotope
to investigate the presence of a heavy metal ion transporter in
the lysosomal membrane. Since, so far, all characterized cop-
per transporters are belonging to the class of P-type ATPases
[11], we investigated the transport of 110mAg in the presence
and absence of ATP. It is known that heavy metal ions can
easily bind to proteins, disturbing measurements of membrane
transport of these ions [12]. This aspeci¢c binding can be
reduced by the addition of glutathione (GSH) [13]. Therefore,
in all our transport assays GSH was present. Appreciable
uptake of 110mAg was observed in rat liver lysosomal mem-
brane vesicles. Fig. 1A shows that Ag uptake (7.5 WM) was
stimulated by ATP. To determine whether the amount of Ag
observed in uptake assays is due to real uptake (internaliza-
tion) or binding on the outside membrane, osmotic shrinking
experiments were performed. In these experiments increasing
of the medium osmolarity leads to shrinking of the vesicles
(i.e. the internal volume gets smaller, while the membrane
surface is constant). As shown in Fig. 1B, the amount of
Ag associated with the vesicles decreased with increasing os-
molarity of the external medium. This indicated that Ag is
transported into an osmotically active intravesicular space.
Extrapolation of these data to an in¢nite high medium osmo-
larity (i.e. a negligible intravesicular volume) revealed the
amount of 110mAg which is not taken up, but which is present
bound to the outside membrane. The same binding compo-
nent is seen in control assays (both lines of Fig. 1B cross the
Y-axis at approximately the same point). Furthermore, the
same aspeci¢c binding component was observed when assays
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Fig. 1. A: 110mAg uptake in lysosomal membrane vesicles is stimu-
lated by ATP. Membrane vesicles (100 Wg of protein) were pre-incu-
bated at 20‡C for 10 min in medium containing 50 mM KHEPES,
pH 7.4, 10 mM GSH, 5 WM valinomycin, and 5 WM FCCP. Assays
at 37‡C were started by the addition of 7.5 WM 110mAg, 10 mM
GSH in the presence (b) or absence (a) of 4 mM ATP. All data
are corrected for aspeci¢c binding as measured at 0 min incubation.
B: E¡ect of increasing medium osmolarity by sucrose on Ag uptake
in lysosomal membrane vesicles. Lysosomal membrane vesicles were
pre-incubated in 50 mM KHEPES, pH 7.4, 10 mM GSH, 5 WM va-
linomycin, 5 WM FCCP, and with 0.25^1 M sucrose for 30 min at
20‡C. Vesicles were then incubated for 5 min at 37‡C with 7.5 WM
110mAg in 50 mM KHEPES, pH 7.4, 10 mM GSH, 0.25^1 M su-
crose and in the presence (b) or absence (a) of 4 mM ATP.
Fig. 2. Carrier mediated uptake of 110mAg into lysosomal membrane
vesicles. Lysosomal membrane vesicles were pre-incubated as de-
scribed in Fig. 1A. 110mAg uptake (5 min, 37‡C) was measured in
the presence of 4 mM ATP and increasing concentrations of Ag,
and corrected for aspeci¢c binding as measured in the presence of
100 WM CuSO4.
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were performed in the presence of high concentrations (s 100
WM) unlabeled AgNO3 or CuSO4 (data not shown). There-
fore, in all subsequent experiments assay blanks were deter-
mined in the presence of high concentrations of CuSO4. Next,
we determined if transport rates of 110mAg uptake were satu-
rable. Initial uptake of 110mAg was studied under zero-trans
conditions at increasing Ag concentrations in the presence of
ATP. All data were corrected for an aspeci¢c binding compo-
nent as measured in the presence of high concentrations of
inhibitor. We observed the typical kinetics of carrier mediated
transport by one single process, with an apparent a⁄nity con-
stant Kt of 16 WM in the presence of ATP (Fig. 2).
3.2. Substrate speci¢city of the lysosomal heavy metal ion
transporter
To determine the substrate speci¢city of the transporter, we
¢rst tested the cis-inhibition e¡ects of several metal ions. A
clear cis-inhibition of 110mAg uptake was seen with Ag, Cu2
and Cd2, but not with Fe2, Hg2, Mn2, Mo4, Ni2, and
Zn2 (Fig. 3A). To determine the mode of inhibition, initial
uptake of 110mAg was measured at increasing Ag concentra-
tions in voltage clamped membranes with K/valinomycin, in
the absence and presence of, respectively, unlabeled CuSO4 or
CdSO4. The results were ¢tted to a double reciprocal plot,
showing a clear mode of competitive inhibition of CuSO4
(Ki of 17 WM) and of CdSO4 (Ki of 28 WM) on 110mAg trans-
port (Fig. 3B). These results demonstrated that Ag, Cu, and
Cd are recognized by the same protein in the lysosomal mem-
brane.
3.3. Ag uptake by lysosomal membrane vesicles is stimulated by
ATP hydrolysis
So far, all known copper transporters are P-type ATPases
[11]. We investigated if the lysosomal heavy metal ion trans-
porter also belongs to this group of P-type ATPases. To test if
ATP stimulation of Ag uptake by lysosomal membrane
vesicles is dependent on ATP hydrolysis, we tested two non-
hydrolyzable analogues of ATP, adenosine 5P-[L,Q-methylene]-
triphosphate tetralithium (AMP-PCP) and 5P-adenylylimido-
diphosphate (AMP-PNP). Both ATP analogues did not stim-
ulate Ag uptake in comparison to the control level (AMP
level) (Table 1). This indicated that ATP hydrolysis is required
for the stimulation of Ag uptake by lysosomal membrane
vesicles. Besides ATP, also other triphosphates, CTP and
GTP, but not the monophosphates AMP, CMP, and GMP
were able to stimulate Ag uptake, indicating that generally
hydrolysis of high energy phosphate bonds is required for
transport (Table 1). The e¡ect of speci¢c ATPase inhibitors
and protein modi¢ers on the Ag uptake by the lysosomal
membrane vesicles was investigated. Vanadate, acting as a
phosphate analogue, is considered to be a speci¢c inhibitor
of several P-type ATPases [14], inhibiting ATP hydrolysis at
micromolar concentrations. As shown in Table 2, Ag trans-
port by the lysosomal carrier was not inhibited by vanadate.
This is in accordance with an earlier report [15] that P-type
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Fig. 3. A: Cis-inhibition of metal ions on the ATP stimulated up-
take of 110mAg. Lysosomal membrane vesicles were incubated for
5 min at 37‡C in the presence of 7.5 WM 110mAg, 50 mM KHEPES,
pH 7.4, 10 mM GSH, 5 WM valinomycin, 5 WM FCCP, 4 mM
AMP or ATP and 100 WM of the indicated metal sulfates. Values
are mean þ S.D. of two experiments performed in duplicate and cor-
rected for aspeci¢c binding as measured in the presence of 100 WM
CuSO4. B: Competitive inhibition of 110mAg transport by CuSO4
and CdSO4. Initial uptake rates of 15 WM 110mAg were measured at
increasing Ag concentrations in pre-incubated lysosomal membrane
vesicles, as described in Fig. 1. Data were corrected for aspeci¢c
binding as measured in the presence of 500 WM CuSO4. Data were
plotted double reciprocally, without inhibitor (b), with 25 WM unla-
beled CuSO4 (a) or with 25 WM unlabeled CdSO4 (+). As reported
in the text Kis were calculated by the following equation: Ki = Kt[I]/
{(31/x)3Kt} (Kt is the Km for Ag, [I] is the inhibitor concentration,
x is the intercept on the abscissa).
Table 1
E¡ects of monophospho- and triphosphonucleotides, and non-
hydrolyzable ATP analogues on Ag uptake into lysosomal mem-
brane vesicles
Tested compound Transport activity
pmol/mg/5 min % of control
Nonea 92.5 þ 0.7
Nucleotide
ATP 145.8 þ 18.6 158
CTP 148.2 þ 0.6 160
GTP 115.4 þ 24.8 125
AMP 83.7 þ 6.8 91
CMP 89.4 þ 4.9 97
GMP 78.1 þ 21.4 85
Non-hydrolyzable ATP-analogues
AMP-PCP 89.6 þ 12.0 97
AMP-PNP 77.6 þ 14.4 84
aNet uptake in the presence of 50 mM KHEPES, pH 7.4, corrected
for aspeci¢c binding as measured in the presence of 100 WM CuSO4,
was set to 100%. All uptakes are performed in the presence of 4 mM
of the indicated compounds, incubated for 5 min at 37‡C and are
corrected for aspeci¢c binding.
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ATPases with a speci¢city for heavy metal ions seem to be
resistant to vanadate inhibition. None of the other tested AT-
Pase inhibitors inhibited Ag uptake (Table 2). Surprisingly,
only the protein modi¢er DIDS showed a slight inhibition
of transport in the presence of ATP. In fact, inhibition of
transport was observed to the level of control transport
(AMP). Apparently, ATP stimulation was inhibited by
DIDS. This indicated that lysine residues (modi¢ed by
DIDS) may play a role in the binding of ATP (anion).
3.4. 110mAg uptake in puri¢ed intact lysosomes
All our previous studies made use of lysosomal membrane
vesicles. Such vesicles are a mixed population of inside-out
and right-side-out vesicles [2]. To investigate if the lysosomal
heavy metal ion transporter functions physiologically as an
importer or exporter, we performed uptake studies using in-
tact lysosomes. These highly puri¢ed lysosomes, isolated by
Percoll gradient centrifugation, showed ATP stimulated
110mAg uptake similar to that observed in lysosomal mem-
brane vesicles. The increase of the external medium osmolar-
ity by the addition of sucrose (leading to shrunken lysosomes)
resulted in a concomitant decrease of 110mAg uptake (Fig.
4), demonstrating import into the intralysosomal compart-
ment.
3.5. The lysosomal heavy metal ion transporter is not a¡ected
in an animal model for Wilson disease
The Long Evans Cinnamon (LEC) rat is a biochemical and
genetic animal model for human Wilson disease [16,17]. The
gene mutated in this disease normally encodes for a copper P-
type ATPase. The LEC rats show a reduction in the rate of
incorporation of copper into ceruloplasmin and a reduction in
the biliary excretion of copper. A decreased biliary copper
secretion due to a lysosomal defect has been suggested for
Wilson disease [5,18,19]. Therefore, we investigated the Ag
transport in lysosomal membrane vesicles of 7-week-old
LEC rats. No signi¢cant di¡erence in 110mAg transport was
observed in vesicles from both normal and LEC rats (160 and
228 nmol/mg/1 min incubation and 381 and 349 nmol/mg
protein/5 min incubation, respectively). Apparently, this newly
described lysosomal heavy metal ion (copper) transporter is
not a¡ected.
4. Discussion
In the present study we provide biochemical evidence for
the presence of a heavy metal ion transport system in the
lysosomal membrane stimulated by ATP hydrolysis. Our stud-
ies on Ag transport were complicated by aspeci¢c binding of
the free metal ions to proteins. Addition of excess glutathione
was necessary to reduce the aspeci¢c binding of Ag to the
membranes. Similar problems have been encountered with
copper transport across biological membranes [13,20,21]. In
our experiments, at least 60% of the vesicle-associated silver
was the result of carrier-mediated transport into an osmoti-
cally sensitive vesicle.
The heavy metal ions, Ag, Cu, and Cd competitively inhib-
ited 110mAg uptake into the lysosomal membrane vesicles,
while many others did not. This demonstrates that the lyso-
some contains a carrier with a speci¢city for a limited number
of metal ions. This carrier is di¡erent from the recently iden-
ti¢ed general metal-ion carrier, DCT1 (divalent-cation trans-
porter), which has a much broader substrate speci¢city, in-
cluding Fe, Zn, Mn, Co, Cd, Cu, Ni and Pb, and is present
in the plasma membrane [22]. While Cd is only occurring as a
divalent cation and Cu as a mono- or divalent cation, Ag is
only occurring as a monovalent cation. Hence, this lysosomal
transport system apparently does not discriminate monovalent
from divalent ions. We assume that Ag forms a complex with
GSH and that this complex is recognized by the transport
protein. Since the lysosomal membrane is impermeable to
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Fig. 4. E¡ect of increasing medium osmolarity by sucrose on Ag
uptake in intact lysosomes. Percoll gradient isolated intact lyso-
somes were pre-incubated in 50 mM KHEPES, pH 7.4, 10 mM
GSH, 5 WM valinomycin, 5 WM FCCP, and with 0.25^1 M sucrose
for 1 h at 20‡C. Lysosomes were then incubated for 5 min at 37‡C
with 15 WM 110mAg in 50 mM KHEPES, pH 7.4, 10 mM GSH,
0.25^1 M sucrose and in the presence (b) or absence (a) of 4 mM
ATP.
Table 2
E¡ect of ATPase inhibitors and protein modi¢ers on Ag uptake into lysosomal membrane vesicles
Tested compound Concentration (mM) Transport activity Target
pmol/mg/5 min % of uptake
ATP 4 307.1 þ 4.2 ^ ^
AMP 4 178.5 þ 20.1 58 ^
ATP+KNO3 50 313.8 þ 28.5 102 V-type ATPase
ATP+N-ethylmaleimide 1 335.5 þ 53.9 109 V-type ATPase
ATP+ba¢lomycin A1 0.001 283.9 þ 9.3 93 V-type ATPase
ATP+NaN3 5 333.6 þ 30.4 109 F-type ATPase
ATP+VO334 0.1 296.7 þ 30.2 97 P-type ATPase
ATP+DIDS 1 156.3 þ 27.9 51 Anion carriers
Assays were performed in the presence of ATP or AMP or in the presence of ATP and the indicated compounds for 5 min at 37‡C and corrected
for aspeci¢c binding as measured in the presence of 100 WM CuSO4. The uptake in the presence of ATP was set to 100%.
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GSH [23], Ag is released from the complex, and is transported
as a free monovalent ion into the vesicles.
Based on sequence similarities, about 20 putative copper
ATPases have been identi¢ed from various sources [11], all
belonging to the subclass of heavy metal ion P-type ATPases,
i.e. the CPx-type ATPases (based on a conserved intramem-
branous cysteine-proline-cysteine or cysteine-proline-histidine
motif). Direct evidence for a function in copper transport
exists only for the CopB ATPase (Enterococcus hirae) [24]
and for ATP7A (human), which is defective in Menkes disease
[7]. Both proteins can also transport silver.
The lysosomal heavy metal ion transporter is stimulated by
ATP, but not by non-hydrolyzable ATP analogues. This in-
dicates that hydrolysis is needed for stimulation. This, togeth-
er with its insensitivity to vanadate suggests that the lysoso-
mal transporter belongs to the CPx-type ATPases. Ag uptake
was not only stimulated by ATP, but also by other triphos-
phonucleotides (i.e. CTP and GTP). To our knowledge, stim-
ulation by CTP or GTP has not been tested earlier for the
CPx-type ATPases. However, it is known that other ATP-
dependent transport systems can be stimulated by di¡erent
triphosphonucleotides [25].
In our studies the metals (Ag, Cu, and Cd) are supplied to
the lysosomal transporter as complexes with GSH. Several
transport systems have been demonstrated for the transport
of GSH-complexes (e.g. the canalicular multispeci¢c organic
anion transporter (cMOAT)) [26]. However, a similar GSH-
complex transport is unlikely in our studies for the following
reasons: (i) our lysosomal system recognizes also monovalent
ions (Ag), while substrates of cMOAT are supposed to have
at least two negative charges (e.g. GS3..Zn..3SG) [27]; (ii)
the lysosomal transporter has a much more restricted sub-
strate speci¢city for Ag, Cu, and Cd, with competitive inhib-
ition among di¡erent metal ions; (iii) moreover, the lysosomal
membrane is reported to be impermeable to GSH [23].
It is interesting to speculate on a possible physiological
function of this new lysosomal heavy metal ion transporter.
Both ATP stimulation (the intra-lysosomal lumen does not
contain ATP) and transport into intact lysosomes suggest
that this carrier functions as a lysosomal importer for copper
and cadmium, with an extralysosomal ATP-binding site. Sil-
ver, which is also recognized by this importer, is not known to
have any physiological function. Under certain conditions,
import of copper may be required for storage or disposal. A
decreased biliary excretion of copper leads to hepatic accumu-
lation of this heavy metal. Several hypotheses, including de-
fective transporters, have been proposed to explain the defec-
tive biliary copper excretion in Wilson disease [28]. It has been
demonstrated that in conditions of hepatic overload, the ma-
jor route for biliary copper excretion is exocytosis of lysoso-
mal contents into biliary canaliculi [5]. Since the transport
observed in LEC rats, an animal model for Wilson disease,
was not a¡ected, this new lysosomal heavy metal ion trans-
porter does not play a role in the release of copper into the
bile. However, it may explain the mechanism by which copper
is taken up into the lysosomes during overload conditions [5].
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